With the volume and accessibility of scientific research increasing across the world, it has never been more important to continue building the reputation for quality and ethical publishing we’ve spent the past two centuries establishing. 622-95-7, Name is 1-(Bromomethyl)-4-chlorobenzene, SMILES is ClC1=CC=C(CBr)C=C1, in an article , author is Zhang Haiming, once mentioned of 622-95-7, Electric Literature of 622-95-7.
Four series of derivatives, 6-substituted-1,2,4-triazolo[3,4-a] phthalazine derivatives and 6-substituted tetrazolo[5,1-a] phthalazine derivatives have been synthesized. The structures of compounds are confirmed by H-1 NMR, C-13 NMR, IR and HRMS. The anticonvulsant effects of the compounds are evaluated with maximal electroshock test by intraperitoneally injected in mice. The experimental results show that N-(4-bromophenyl) tetrazolo[5,1-alpha]phthalazin-6-amine (7a) was the most potent compound, with a median effective dose of 5.89 mg circle kg(-1). Its anticonvulsant effect is better than the reference drug, carbamazepine.
Electric Literature of 622-95-7, Enzymes are biological catalysts that produce large increases in reaction rates and tend to be specific for certain reactants and products. I hope my blog about 622-95-7 is helpful to your research.
Reference:
Phthalazine – Wikipedia,
,Phthalazine | C8H6N2 – PubChem